MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 21, 2008; DOI: 10.1124/mol.108.046953


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.046953v1
74/1/289    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixit, V.
Right arrow Articles by Juliano, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixit, V.
Right arrow Articles by Juliano, R. L.


Received for publication March 12, 2008.
Revised April 18, 2008.
Accepted for publication April 18, 2008.

Selective Killing of Smad4-Negative Tumor Cells Via A Designed Repressor Strategy

Vidula Dixit 1 Rudolph L. Juliano 1*

1 University of North Carolina

* Address correspondence to: E-mail: arjay{at}med.unc.edu

Abstract

Smad4 is a key tumor suppressor that is frequently deleted or inactive in pancreatic and colon tumors. In this report we describe an approach for attaining selective killing of Smad4 deficient tumor cells. Using a vector system involving a designed repressor with zinc finger binding domains and the HSV-TK 'suicide gene', we demonstrate Smad4 responsive regulation of HSV-TK expression and consequent altered susceptibility to the pro-drug ganciclovir (GCV). In pancreatic tumor cell lines stably transfected with the vector system, a robust differential of HSV-TK expression and GCV toxicity was attained depending on the presence or absence of co-transfected Smad4. In matched colon tumor cell lines lacking Smad4 or expressing physiological levels of Smad4, an Adenoviral version of the vector system attained a significant degree of preferential killing of Smad4 negative tumor cells in response to GCV. These findings demonstrate the possibility of achieving selective killing of pancreatic and colon cells depending on their Smad4 status.


Key words: Transcriptional coactivators, Regulation of gene expression, Overexpression, Transcription targets, Tumor suppressors





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics